Last updated: 2026-09-05 18:44:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Twist Bioscience Corporation (TWST) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $124.82, with a market capitalization of $8.47B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $23.30 to $155.44. This page covers its latest market performance, valuation, price trends and company information.
$8.47B | |
$125.19 | |
$214.07 | |
$11.46 | |
$128.71 | |
779.63K | |
1.77M | |
-- | |
$155.44 | |
$23.30 | |
-- | |
-- |
Twist Bioscience Corporation (TWST) last closed at $128.71 as of 2026-09-04 23:31:00, unchanged from the previous close of $128.71.
During the latest regular trading session, TWST traded between $11.46 and $214.07, with a volume of 779.63K shares. The closing price was near the middle and near the upper end of its 52-week range.
Over the past seven days, Twist Bioscience Corporation (TWST) moved from $153.10 to $124.82, representing a decline of 18.47% ($28.28).
The stock traded between $123.75 and $155.44 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.38 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 76.8%
TWST is currently trading at $124.82, placing it 76.8% of the way from its 52-week low of $23.30 to its 52-week high of $155.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 979 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Twist Bioscience Corporation (TWST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.